Shaanxi Dideu MedichemRetatrutide
Ordered Retatrutide from Shaanxi Dideu Medichem? Mail in a sample (US only) and let us test it for free.
Test my supplyShaanxi Dideu Medichem's Retatrutide record is mixed: a January identity failure with 0 mg and later -40% underfill/+188% overfill drag down high-purity passes. Recent June tests with batch IDs look cleaner, but it is a short rebound.
We investigated who actually operates Shaanxi Dideu Medichem — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shaanxi Dideu Medichem rows.
Cancel anytime
About Shaanxi Dideu Medichem test results from Finnrick
Shaanxi Dideu Medichem is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 10 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shaanxi Dideu Medichem peptides in this dataset are Retatrutide (10 tests), BPC-157 (0 tests) and Tirzepatide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 10 recent tests.
Ordered Retatrutide from Shaanxi Dideu Medichem? Mail in a sample (US only) and let us test it for free.
Test my supply